Heightened levels of plasma growth differentiation factor 15 in men living with HIV

Physiological Reports

Huaizhu Wu¹  Neeti Agarwal²  Reina Armamento‐Villareal²  Sean M. Hartig²  Ashok Balasubramanyam²  Claudia E. Ramirez Bustamante²  Jordan E. Lake³ 

[1] Atherosclerosis and Lipoprotein Research Baylor College of Medicine Houston Texas USA;Division of Diabetes, Endocrinology, and Metabolism Baylor College of Medicine Houston Texas USA;Division of Infectious Diseases Department of Internal Medicine McGovern Medical School University of Texas Health Science Center Houston Texas USA;

关键词: ART;    energy balance;    GDF15;    HIV;    metabolic syndrome;   

DOI  :  10.14814/phy2.15293

来源: DOAJ

【 摘 要 】

Abstract Plasma biomarkers that reflect energy balance disorders in people living with HIV (PLWH) remain limited. Growth differentiation factor 15 (GDF15) abundance in plasma of mice and humans induces negative energy balance but also becomes highly elevated in obesity and other metabolic diseases. We sought to compare plasma GDF15 levels in PLWH and HIV‐negative persons and mouse models expressing the HIV accessory protein Vpr (that recapitulate HIV‐associated metabolic disorders) and determine their relationship to metabolic parameters. We measured liver Gdf15 mRNA levels and plasma GDF15 levels in male Vpr mice and littermate controls. In parallel, we analyzed plasma GDF15 levels in 18 male PLWH on stable, long‐term antiretroviral therapy and 13 HIV‐negative men (6 healthy controls and 7 with metabolic syndrome). Plasma GDF15 levels were correlated with anthropometric and immune cell parameters in humans. Gene expression analysis of Vpr mouse liver demonstrated elevated Gdf15 mRNA. Plasma GDF15 levels were also higher in Vpr mouse models. Levels of plasma GDF15 in PLWH were greater than in both HIV‐negative groups and correlated positively with the CD4/CD8 T cell ratio in PLWH. Plasma GDF15 levels correlated positively with age in the HIV‐negative subjects but not in PLWH. Since GDF15 levels predict fatty liver disease and energy balance disorders, further studies are warranted to determine the effect of GDF15 in mediating the metabolic disturbances that occur in Vpr mice and PLWH.

【 授权许可】

Unknown